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Between people with dementia  
and their caregivers 
Sensor-based, context-sensitive,  
evolving, personalised 
offer encouragement,  
warnings, alerts 
Clinician loop 
Faithful log of health-related  
information, 
Summaries, trends, pattern analysis 
Monitor improvement, stasis or 
warn clinician of deterioration  
Supports care decisions 
The Dem@Care Project 







ADL/IADL SOCIAL INTERACTION 
MOOD 
Meal/Drink preparation and 
consumption, daily tasks 
(e.g. watch tv, listen to 
music, read, hobbies, 
chores) 
Night time sleep, awakenings, bed 
exits, Difficulty falling asleep, insomnia 
onset, day-time sleep and napping 
Amount of physical 
activity in the home, 












contact, initiated and 
received phone contact, 
speech analysis  
Dem@Home Sensor Toolbox 







4 Raw accelerometer data























The Dem@Care System 
 Clinician is able to 
monitor 
 Sensors recordings 
 Analysis results (e.g. 
completed activities) from 
the current or previous 
dates/periods 
 
 Person with dementia 
and the carer are able to 
read messages-prompts-
advice that come from  
 The System 
 Clinician  
Dem@Care: Aims and Methodology 
 Research Questions 
 @Lab: Can Dem@Care contribute to the assessment of dementia 
above and beyond traditional assessment methods? 
 @NH: Can Dem@Care effectively support nursing home staff to 
care for people with severe dementia (including BPSD) 
 @Home: Can Dem@Care optimise the functional status of the 
PwD and support their independence and autonomy 
 
 Methodology 
 @Lab: Quantiative between group (Healthy, MCI, AD); n=380 
 @NH and @Home: Multiple case study design; n=13 
 @H: Multiple case study design; n=16 
 Four beneficiary groups  
 the PwD, informal caregivers, the clinician, and formal care staff 
 Stakeholders 
 end-users, academics and professionals, and policy-makers  
 
 Personal Impact:  Quality of life (PwD/Carer) 
 Independence, Sense of Improvement, Security & Safety 
 Social and Economic Impact:  Builds from personal impact 
 Social inclusion, increased understanding of BPSD 
 Early diagnosis increases, staff costs reduce, at home for longer 





Personal and Societal Impact 
Personal Impact - People with Dementia 
 Increased autonomy and independence in daily life 
 “I feel kind of in control, do you know what I mean? In control of 
my day.” [@H PwD] 
 Sense of improvement across the five domains addressed 
 “Well I couldn’t imagine that I can wake up after 8 o’clock in the 
morning. I used to wake up before 5 o’clock”   [@H PwD] 
 “I see my father is getting better! He is more active and walking a 
lot”   [@H Carer] 
 “We are talking a lot more now … we are finding it easier to talk”   
[@H Carer] 
 Improved diagnosis and management of care 




Personal Impact – Informal Caregivers 
 Key carer concerns: taking medication and eating 
properly, sleep, adequate physical exercise and stimulation 
 Improvements for the person with dementia translated into 
improvements for their informal caregivers 
 “It is a feeling of safety and relief that every caregiver of an elder 
person must have”   [@H Carer] 
 Increased independence for some caregivers 
 “I’m going away for the week in September …. He’s independent at 
the moment as we are trying to keep him as independent as long as 
we can… I used to give him his tablets, now he takes them himself”   
[@H Carer] 
 But, carer independence was most related to the severity of dementia  
 Overall sense of improvement in quality of life 






Personal Impact – Clinicians/Formal Carers 
 Facilitate timely and accurate diagnosis while delivering 
efficiencies in terms of time and cost 
 Improved assessment/diagnostic procedures (incl differential diagnosis) 
 Improvements in clinical reasoning (@NH) 
 Reduction in observer bias 
 More timely identification and better understanding of 
functional, behavioural, and emotion pattern changes 
 “I was able to identify problems and issues [e.g. REM sleep] that otherwise 
would have been impossible” [Clinician] 
 Improved capacity and quality of care. Formal carers can:  
 develop and evaluate personalised interventions 
 better manage the care of the person with dementia 
 better manage the emotional and social disturbances of the Behavioural and 



































 Economic: Cost efficiencies  
 Time savings (diagnosis/assessment) 
 Improved workflow, clinical 
reasoning, and intervention selection 
 Potential to reduce costs for national 
healthcare systems 
 Potential savings in the home 
environment – harder to quantify 
Difficult to evaluate the longer-term 
economic and societal outcomes but 
successful attainment of personal 
impacts for each stakeholder group 




 Social: Inclusion and awareness 
 Improved understanding of BPSD 
and reduction in social disturbance 
and therefore isolation @NH 
 Manage appointments and remain 
connected with life outside the home 
 Engagement with new social groups 




Scientific Impact: Advancing Technical SoA 
 Novel visual-sensing algorithms 
 New approaches for perceptual analysis of egocentric video content 
 Advanced physiological sensing and audio sensing 
 Highly accurate real-time event detection and people tracking 
 Creation of new knowledge structures, reasoning methods, 
rules, associations, and algorithms 
 Intelligent machine learning and dynamic model adaptation 
 Novel context-aware multi-sensor, intelligent, event-driven 
feedback mechanisms 
 Adaptive visualisations of daily activities 
 Personalised alerts enabling scheduled problem checks and other 
automated interventions 






Scientific Impact: Advancing Clinical SoA 
 Novel and holistic solution supporting all aspects of the 
clinical management of dementia  
 Assessment and diagnosis 
 Improved early detection of dementia over and above traditional 
assessment methods alone – ability to detect subtle behaviour changes 
 Successfully differentiate between healthy, MCI and AD patients 
 Improved assessment of circumstances surrounding BPSD and their 
contribution to the expression of BPSD for an individual 
 Treatment and care 
 Preventative care decision-making 
 Timely updating of care plans for the person with dementia 
 Potential to support clinical trials 
 Selection and enrolment of participants 





 Informed consent 
 High-tech nature of AAL may make it difficult for the PwD to fully 
understand what they are consenting to => Rolling consent 
 Ambient monitoring requires additional third party consent – no 
agreement in the literature as to how this should be handled 
 Privacy and surveillance 
 Impaired cognitive status does lead to situations where data is captured 
that the PwD would not want to be captured 
 Risk of surveillance when monitoring ADLs or monitoring off-site 
 Carers do not always understand the ethical implications 
 Best interests of the person with dementia 
 Risk of replacing or reducing human interaction 
 Discussion time with clinicians needs to be preserved 
 Importance of therapeutic face-to-face contact highlighted @H 
Scientific Impact: Advancing Ethical Debate 
Conclusions 
 Value of objective ongoing assessment 
 Analysis of sensor level data shows promising results although the 
real value of the Dem@Care system is the ability to: 
 Triangulate data from various sensors measuring varied domains 
 Identify improvement, stasis, and/or deterioration over time  
 
 Supports that enable Dem@Home use 
 Easy to use sensors, data transfer, and automated feedback 
 Caregiver is still required as primary source of support 
 Clinician needs to make the effort to ensure that people understand 
how ICT can and may not help, and that informed consent is given 
 Importance of well-supported training periods 
 Importance of personal interaction with the clinician (or researcher) 
 Perceived benefits must be stronger than the perceived effort to use 
the technology 
Conclusions 
 Personal impacts found for all beneficiaries and stakeholders 
 Value of objective ongoing assessment/triangulation of data 
 Improved clinical assessment of a person’s cognitive, functional, and 
emotional status in a familiar environment 
 Supports ongoing monitoring of improvement, stasis, or decline 
 Individualisation of interventions and treatment plans 
 Improvements for person with MCI/dementia based on feedback and 
monitoring 
 Potential for increased carer independence 
 
 Advancement of technical, clinical and ethical state of the art 
 
 But, difficult to evaluate economic and social impacts as:  
 Not all projects include a health economics element 
 Projects typically don’t run for long enough (esp. development projects) 
 Need to develop short-term metrics that we know deliver benefits in the 
longer-term 
Thank you for your attention 
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